|
MechanismEPO receptor agonists [+1] |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseWithdrawn |
First Approval Ctry. / Loc. |
First Approval Date18 Mar 2002 |
100 Clinical Results associated with Shire Pharmaceutical Contracts Ltd.
0 Patents (Medical) associated with Shire Pharmaceutical Contracts Ltd.
100 Deals associated with Shire Pharmaceutical Contracts Ltd.
100 Translational Medicine associated with Shire Pharmaceutical Contracts Ltd.